BridgeBio’s big week, Lilly’s Alzheimer’s data, & succession at Stanford

What's your favorite Homeric text?

July 21, 2023 Check out STAT+

Sponsored By

What can Homer teach us about biotech? Has Big Science gotten too big? And what's the future of treating Alzheimer's disease? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser